DataString Consulting Company Logo
DataString Consulting Company Logo
Positron Emission Tomography Market
Home»Recent Reports»Positron Emission Tomography Market

Positron Emission Tomography Market

Author: Debadatta Patel - Senior Consultant, Report ID - DS1801131, Published - February 2025

Segmented in Product Type (Clinical PET Scanners, Preclinical PET Scanners, Mobile PET Scanners), Application (Oncology, Cardiology, Neurology, Others), Component, Technology, End Users and Regions - Global Industry Analysis, Size, Share, Trends, and Forecast 2024 – 2034

Share this report:

Global Positron Emission Tomography
Market Outlook

The market, for Positron emission tomography was estimated at $2.9 billion in 2024; and it is anticipated to increase to $4.3 billion by 2030 with projections indicating a growth to around $5.9 billion by 2035. This expansion represents a compound annual growth rate (CAGR) of 6.8% over the forecast period. The growing importance of Positron Emission Tomography in the field of imaging is evident in the expected increase in numbers presented here. Various factors are contributing to this trend such as advancements in radiopharmaceuticals and the rising incidence of cancer and heart diseases along with an increasing awareness and demand for early diagnosis methods among patients. This rise is an outcome of the ongoing suitability and promise of Positron Emission Tomography across different diagnostic and treatment procedures that underscore its significant position, in the healthcare industry. The Positron Emission Tomography market is set to create chances, for advancement and creativity that will resonate across the healthcare industry with a sense of vitality and progressiveness.


Utilizing a method in nuclear medicine known as Positron Emission Tomography (PET) a detailed three dimensional portrayal of the bodys functional processes is created with precision and clarity. This innovative technology seamlessly integrates both physiological data to transform the approach to diagnosing and treating various conditions such as cancer, Alzheimers disease and cardiovascular ailments. The profound impact of PET extends beyond realms by significantly improving patient outcomes and playing a pivotal role, in driving up healthcare needs.


Market Size Forecast & Key Insights

2019
$2.9B2024
2029
$5.5B2034

Absolute Growth Opportunity = $2.7B

The Positron Emission Tomography market is projected to grow from $2.9 billion in 2024 to $5.5 billion in 2034. This represents a CAGR of 6.8%, reflecting rising demand across Oncology Diagnostics, Cardiology and Neurology.

The Positron Emission Tomography market is set to add $2.7 billion between 2024 and 2034, with manufacturer targeting Cardiology & Neurology Application projected to gain a larger market share.

With Increasing prevalence of cancer, and Technological advancements in medical imaging, Positron Emission Tomography market to expand 93% between 2024 and 2034.

Opportunities in the Positron Emission Tomography Market

Integrating AI Technology

The combination of Positron Emission Tomography with advancements such as AI shows potential for advancement in various areas. The integration of AI to enhance image analysis and boost precision could elevate the practicality of Positron Emission Tomography, in clinical settings and broaden its market reach.

Expanding Applications in Neurology and Emergence in Oncology

The rise in conditions like Alzheimers and Parkinsons has led to a greater need for accurate and early diagnostic methods in the medical field. Positron Emission Tomography stands out for its imaging technology that could play a crucial role in meeting this pressing demand. Its application in neurology opens up prospects, for market expansion and growth like never before.

In the battle against cancer worldwide becoming more intense every day the importance of accurate diagnostic technologies such as Positron Emission Tomography is rising significantly. Its capability to pinpoint cells in their early development could potentially revolutionize cancer treatment by making it more efficient. Nations with rates of cancer cases such as the United States and China may experience a notable increase in the demand, for this technology.

Growth Opportunities in North America and Asia-Pacific

Asia Pacific Outlook

The Asia Pacific region holds potential for the PET industry due to its aging population and rising chronic disease rates alongside a growing middle class segment. There is a surge in demand driven by increased healthcare spending and urbanization trends well as an improved understanding of early disease identification. Furthermore government funding in healthcare technology and the expanding neurology field are factors boosting the adoption of PET technologies, in this region. In the Asia Pacific regions PET market stands out for its competitive environment fueled by the strong presence of local companies that hold considerable sway in the industry landscape. Neuxoft Medical Systems and United Imaging are standout players leveraging technology to stay ahead, in the market.

North America Outlook

Renowned for its role in advancing technology and healthcare breakthroughs globally North America stands out as a key market for Positron Emission Tomography . With a established healthcare system and substantial investment in health initiatives the region exhibits a notable uptick in PET usage for detecting cancer, neurological conditions and heart related issues. The markets vibrancy is fueled by an emphasis, on research and development which drives the creation and introduction of cutting edge PET solutions. In addition to this point of view. Its crucial to recognize that having thought out competitive plans is essential for navigating the highly competitive environment in this region. Companies like GE Healthcare and Philips Healthcare are, at the forefront of shaping the markets development and direction.

North America Outlook

Renowned for its role in advancing technology and healthcare breakthroughs globally North America stands out as a key market for Positron Emission Tomography . With a established healthcare system and substantial investment in health initiatives the region exhibits a notable uptick in PET usage for detecting cancer, neurological conditions and heart related issues. The markets vibrancy is fueled by an emphasis, on research and development which drives the creation and introduction of cutting edge PET solutions. In addition to this point of view. Its crucial to recognize that having thought out competitive plans is essential for navigating the highly competitive environment in this region. Companies like GE Healthcare and Philips Healthcare are, at the forefront of shaping the markets development and direction.

Asia-Pacific Outlook

The Asia Pacific region holds potential for the PET industry due to its aging population and rising chronic disease rates alongside a growing middle class segment. There is a surge in demand driven by increased healthcare spending and urbanization trends well as an improved understanding of early disease identification. Furthermore government funding in healthcare technology and the expanding neurology field are factors boosting the adoption of PET technologies, in this region. In the Asia Pacific regions PET market stands out for its competitive environment fueled by the strong presence of local companies that hold considerable sway in the industry landscape. Neuxoft Medical Systems and United Imaging are standout players leveraging technology to stay ahead, in the market.

Growth Opportunities in North America and Asia-Pacific

Established and Emerging Market's Growth Trend 2025–2034

1

Major Markets : United States, Germany, Japan, China, United Kingdom are expected to grow at 4.4% to 6.5% CAGR

2

Emerging Markets : India, Brazil, South Korea are expected to grow at 7.8% to 9.4% CAGR

Market Analysis Chart

Pet scans are known for their accuracy in detecting cancer and other health issues like disorders and heart problems due to the advanced technology they use called positron emission tomography . The growing demand for PET technology is driven by factors such as the rise in diseases and advancements in radiopharmaceuticals and research efforts to improve diagnostics for conditions, like cancer.

Recent Developments and Technological Advancement

December 2024

Siemens Healthineers introduced a cutting edge PET scanner with enhanced resolution capabilities to surpass the limitations of Positron Emission Tomography devices and strengthen its position, in the market.

October 2024

GE Healthcare unveiled a software, for Positron Emission Tomography that harnesses the power of AI to enhance imaging quality and efficiency for physicians in delivering more precise diagnoses.

July 2024

Philips Healthcare expanded its product offerings by introducing a series of advanced Positron Emission Tomography technologies designed for early detection of dementia in its initial stages. This move has had an impact, on the market dynamics.

In the realm of Positron Emission Tomography notable progress has propelled the industry forward by pushing boundaries and showcasing the increasing capabilities of technology. A prominent trend shaping this sector involves combining PET with diagnostic tools, like MRI and CT scans.

Impact of Industry Transitions on the Positron Emission Tomography Market

As a core segment of the Medical Device industry, the Positron Emission Tomography market develops in line with broader industry shifts. Over recent years, transitions such as Digitalization of PET Scanning and Integration of AI In PET have redefined priorities across the Medical Device sector, influencing how the Positron Emission Tomography market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.

1

Digitalization of PET Scanning:

The Positron Emission Tomography market has undergone a transformation due to the shift towards digitalizing PET scans. Incorporating technology into PET scanning has had a profound impact, by improving image quality and decreasing scan duration. This advancement not only enhances patient comfort but also maximizes resource efficiency boosts diagnostic precision and expedites patient flow. The use of digital PET scanners has given a strategic advantage to different healthcare providers by improving their services and expanding their reach in the industry. This transition to technology has significantly influenced the field of medical imaging by driving progress, towards more accurate and thorough diagnostic solutions.

2

Integration of AI In PET:

There has been a shift observed in the Positron Emission Tomography sector with the incorporation of AI algorithms gaining prominence. AIs capacity to effectively and precisely analyze datasets has proven highly beneficial in the PET technology field. One key area where AI is making an impact in PET imaging is, in improving image interpretation processes which subsequently leads to enhanced accuracy and reduced analysis duration.

Global Events Shaping Future Growth

The chart below highlights how external events including emerging market developments, regulatory changes, and technological disruptions, have added another layer of complexity to the Medical Device industry. These events have disrupted supply networks, changed consumption behavior, and reshaped growth patterns. Together with structural industry transitions, they demonstrate how changes within the Medical Device industry cascade into the Positron Emission Tomography market, setting the stage for its future growth trajectory.

Market Dynamics and Supply Chain

Driver: Increasing Prevalence of Cancer, and Growing Aging Population

The increasing number of cancer cases globally has also paved the way for the advancement of Positron Emission Tomography . This advanced imaging method helps doctors see the inner workings of cancer cells better and tailor treatments effectively to patients needs. As cancer becomes more prevalent and Positron Emission Tomography proves its worth, in healthcare settings worldwide.
The growing number of individuals around the world has also been recognized as a key factor driving the growth of the Positron Emission Tomography market. With aging comes a likelihood of various illnesses such as cancer and neurodegenerative conditions that can also be effectively detected through Positron Emission Tomography scans. Therefore as the worlds population continues to age there is also expected to be a rise in both the usage and need, for Positron Emission Tomography services.
The continuous progress in medical imaging technology is also driving the Positron Emission Tomography market forward at a pace. These advancements enable improved resolution and image quality while enhancing the ability to detect anomalies with sensitivity. Furthermore the integration of AI technologies with Positron Emission Tomography systems is also, on the rise potentially leading to revolutionizing the field.

Restraint: High Cost of Positron Emission Tomography

The high price tag linked to Positron Emission Tomography stands out as an obstacle holding back market progress. It requires top notch technology and trained experts to operate the PET scanners which leads to a substantial cost barrier for numerous healthcare facilities and users thereby hampering market demand significantly. Additionally the expense of PET scans often being shifted onto patients acts as a hurdle in making this advanced imaging method easily accessible putting a notable limit, on market growth.

Challenge: Regulatory Challenges

The field of Positron Emission Tomography faces obstacles due to hurdles that hinder its progress and expansion opportunities worldwide. Regulatory bodies, around the world impose guidelines regarding the utilization and safety protocols of PET Scanners leading to additional time and resources needed by manufacturers seeking product approval and eventual market entry.

Supply Chain Landscape

Raw Material Suppliers

General Electric

Siemens AG

Component Manufacturers

Philips Healthcare

Toshiba Corporation

Equipment Producers
Hitachi Medical Corporation / Shimadzu Corporation
End Users
Diagnostic Centres / Hospitals / Research Institutes
Raw Material Suppliers

General Electric

Siemens AG

Component Manufacturers

Philips Healthcare

Toshiba Corporation

Equipment Producers

Hitachi Medical Corporation

Shimadzu Corporation

End Users

Diagnostic Centres

Hospitals

Research Institutes

Banner LogoBanner Logo

Leading Providers and Their Strategies

Application AreaIndustryLeading Providers / ConsumersProvider Strategies
Oncology
Healthcare
GE Healthcare
Diversifying into advanced techniques for cancer diagnosis including PET scans
Neurology
Medical Imaging
Siemens Healthineers
Integration of AI with PET for improved neurological imaging
Cardiovascular Diseases
MedTech
Philips
Expanding market reach through collaborative research and development
Psychiatry
Clinical Research
Canon Medical Systems
Innovation and development in psychiatric diagnosis with the use of PET scans

Elevate your strategic vision with in-depth analysis of key applications, leading market players, and their strategies. The report analyzes industry leaders' views and statements on the Positron Emission Tomography market's present and future growth.

Our research is created following strict editorial standards. See our Editorial Policy

Applications of Positron Emission Tomography in Cardiology, Neurology and Oncology Diagnostics

Cardiology

Positron Emission Tomography is also crucial in the field of cardiology for purposes and research studies. PET scanners with sensitivity are used to evaluate blood flow in the heart muscle and diagnose ischemic heart disease. Frequently this technology is combined with Magnetic Resonance Imaging to enhance the accuracy of diagnostics. Major companies like General Electric Healthcare dominate the market due, to their PET/MRI scanner offerings.

Neurology

In the field of neurology Positron Emission Tomography plays a role in examining the brains functional alterations that may contribute to neurodegenerative illnesses. By pinpoint glucose metabolism in the brain it assists in recognizing signs typical of ailments such, as Alzheimers and Parkinsons diseases. The distinct benefit of this technology lies in its ability to detect these incapacitating conditions at their onset rendering it highly valuable.

Oncology Diagnostics

Positron Emission Tomography s well known and widely respected use lies in the realm of oncology diagnostics. The PET scan used with the Computed Tomography offers a view of the metabolic activity of cancer cells aiding in detection, staging and tracking various cancers. Leading companies such, as Siemens Healthineers and Philips Healthcare are utilizing this technology to transform cancer diagnosis practices. Their advanced PET scanners offer insights that enhance their competitive edge in the market.

Positron Emission Tomography vs. Substitutes:
Performance and Positioning Analysis

In the realm of medical imaging technology such as CT or MRI scans PET imaging stands out due to its ability to provide cellular level visuals. This makes it particularly promising for advancements in oncology and neurology fields where precise imagings crucial. PET scans hold a position in the medical imaging landscape and are essential, for detailed diagnostics and treatment planning.

Positron Emission Tomography
  • Computed Tomography Scan /
  • Magnetic Resonance Imaging
    High-resolution images, early detection of diseases
    Radiation exposure, High cost of procedures
    Advanced diagnostics, less invasive
    High costs, increased patient risk due to exposure to radiation

Positron Emission Tomography vs. Substitutes:
Performance and Positioning Analysis

Positron Emission Tomography

  • High-resolution images, early detection of diseases
  • Radiation exposure, High cost of procedures

Computed Tomography Scan / Magnetic Resonance Imaging / Single photon Emission Computed Tomography

  • Advanced diagnostics, less invasive
  • High costs, increased patient risk due to exposure to radiation

In the realm of medical imaging technology such as CT or MRI scans PET imaging stands out due to its ability to provide cellular level visuals. This makes it particularly promising for advancements in oncology and neurology fields where precise imagings crucial. PET scans hold a position in the medical imaging landscape and are essential, for detailed diagnostics and treatment planning.

Loading...

Research Methodology

This market research methodology defines the Positron Emission Tomography market scope, gathers reliable data, and validates findings using integrated primary and secondary research. Our systematic framework ensures precise market sizing, growth trend analysis, and competitive benchmarking.


Secondary Research Approach


We begin secondary research by defining the targeted market at Country and Regional levels. As part of the Medical Device ecosystem, we analyze Positron Emission Tomography across Hospitals, Diagnostic Centers, and Research Institutes Applications. Our team gathers data systematically from country level ministerial sources, industry associations & federations, trade databases, company annual & quarterly reports and other credential sources, enabling us to map global and regional market size, pricing trends, regulatory standards, and technology advancements.


Key Sources Referenced:


We benchmark competitors such as GE Healthcare, Siemens Healthineers, and Philips Healthcare by reviewing company financial statements, and regulatory filings. Our secondary insights identify key market drivers and constraints, forming the analytical foundation for primary research.


Primary Research Methods


We conduct structured interviews and surveys with industry stakeholders, including Raw Material Suppliers, Component Manufacturers, and Equipment Producers. Our geographic coverage spans Americas (40%), Europe (30%), Asia-Pacific (25%) and Middle East & Africa (5%). Our online surveys generally achieve a response rate of above 65%, and telephone interviews yield 60%, resulting in above 92% confidence level with a ±7% margin of error.


Through targeted questionnaires and in-depth interviews, we capture purchase intent, adoption barriers, brand perception across Segment Type. We use interview guides to ensure consistency and anonymous survey options to mitigate response bias. These primary insights validate secondary findings and align market sizing with real-world conditions.


Market Engineering & Data Analysis Framework


Our data analysis framework integrates Top-Down, Bottom-Up, and Company Market Share approaches to estimate and project market size with precision.


Top-down & Bottom-Up Process


In Top-down approach, we disaggregate global Medical Device revenues to estimate the Positron Emission Tomography segment, using historical growth patterns to set baseline trends. Simultaneously, in Bottom-up approach, we aggregate Country-Level Demand Data to derive regional and global forecasts, which provide granular consumption insights. By reconciling both approaches, we ensure statistical precision and cross-validation accuracy.


We evaluate the supply chain, spanning Raw Material Suppliers (General Electric, Siemens AG), Component Manufacturers (Philips Healthcare, Toshiba Corporation), and Equipment Producers. Our parallel substitute analysis examines Computed Tomography Scan, Magnetic Resonance Imaging, and Single photon Emission Computed Tomography, highlighting diversification opportunities and competitive risks.


Company Market Share & Benchmarking


We benchmark leading companies such as GE Healthcare, Siemens Healthineers, and Philips Healthcare, analyzing their capabilities in pricing, product features, technology adoption, and distribution reach. By assessing company-level revenues and product portfolios, we derive market share comparisons, clarifying competitive positioning and growth trajectories across the ecosystem.


Our integration of data triangulation, supply chain evaluation, and company benchmarking, supported by our proprietary Directional Superposition methodology enables us to deliver precise forecasts and actionable strategic insights into the Positron Emission Tomography market.


Quality Assurance and Compliance


We cross-reference secondary data with primary inputs and external expert reviews to confirm consistency. Further, we use stratified sampling, anonymous surveys, third-party interviews, and time-based sampling to reduce bias and strengthen our results.


Our methodology is developed in alignment with ISO 20252 standards and ICC/ESOMAR guidelines for research ethics. The study methodology follows globally recognized frameworks such as ISO 20252 and ICC codes of practice.

rm

Positron Emission Tomography Market Data: Size, Segmentation & Growth Forecast

Report AttributeDetails
Market Value in 2025USD 3.1 billion
Revenue Forecast in 2034USD 5.5 billion
Growth RateCAGR of 6.8% from 2025 to 2034
Base Year for Estimation2024
Industry Revenue 20242.9 billion
Growth OpportunityUSD 2.7 billion
Historical Data2019 - 2023
Growth Projection / Forecast Period2025 - 2034
Market Size UnitsMarket Revenue in USD billion and Industry Statistics
Market Size 20242.9 billion USD
Market Size 20273.5 billion USD
Market Size 20294.0 billion USD
Market Size 20304.3 billion USD
Market Size 20345.5 billion USD
Market Size 20355.9 billion USD
Report CoverageMarket revenue for past 5 years and forecast for future 10 years, Competitive Analysis & Company Market Share, Strategic Insights & trends
Segments CoveredProduct Type, Application, Component, Technology, End Users
Regional scopeNorth America, Europe, Asia Pacific, Latin America and Middle East & Africa
Country scopeU.S., Canada, Mexico, UK, Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Mexico, Argentina, Saudi Arabia, UAE and South Africa
Companies ProfiledGE Healthcare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems, Hitachi Medical, Neusoft Medical Systems, United Imaging, Mediso Medical Imaging Systems, CMR Naviscan, Spectrum Dynamics Medical and Sofie Biosciences
CustomizationFree customization at segment, region or country scope and direct contact with report analyst team for 10 to 20 working hours for any additional niche requirement which is almost equivalent to 10% of report value

Explore Report Features and Data Packages

Industry Insight Report

$ 4200
Unlock Multi-User Access for just $999 more
i
No Payment Before Report Delivery
Flexible Payment Options
Additional Features
Customization Available
i
Excel Data Pack Included
Free Analyst Support
i
Industry Expert-Validated Insights
100% Confidentiality Guaranteed
Fast Delivery (24–72 hours)
i
Get Report Now

Strategic Growth Advisory

Unrivaled Custom Market Intelligence & Strategic Advisory for Business Growth and Competitive Excellence

  • Assess and prioritize high-value markets with precision
  • Craft tailored entry and expansion roadmaps
  • De-risk investments through rigorous market intelligence
  • Architect dynamic pricing frameworks aligned to value creation
  • Unlock sustainable margin enhancement opportunities
  • Benchmark performance against global industry leaders
  • Strategically realign portfolios to future growth drivers
  • Accelerate commercialization of breakthrough offerings
  • Harness market foresight and technology shifts to fuel innovation

Discover our Strategic Growth Advisory Services »

Table of Contents

Industry Insights Report - Table Of Contents

Chapter 1

Executive Summary

Major Markets & Their Performance - Statistical Snapshots

Chapter 2

Research Methodology

2.1Axioms & Postulates
2.2Market Introduction & Research MethodologyEstimation & Forecast Parameters / Major Databases & Sources
Chapter 3

Market Dynamics

3.1Market OverviewDrivers / Restraints / Opportunities / M4 Factors
3.2Market Trends
3.2.1Introduction & Narratives
3.2.2Market Trends - Impact Analysis(Short, Medium & Long Term Impacts)
3.3Supply Chain Analysis
3.4Porter's Five ForcesSuppliers & Buyers' Bargaining Power, Threat of Substitution & New Market Entrants, Competitive Rivalry
Chapter 4

Positron Emission Tomography Market Size, Opportunities & Strategic Insights, by Product Type

4.1Clinical PET Scanners
4.2Preclinical PET Scanners
4.3Mobile PET Scanners
Chapter 5

Positron Emission Tomography Market Size, Opportunities & Strategic Insights, by Application

5.1Oncology
5.2Cardiology
5.3Neurology
5.4Others
Chapter 6

Positron Emission Tomography Market Size, Opportunities & Strategic Insights, by Component

6.1PET Detectors
6.2Data Acquisition Systems
6.3Imaging Software
Chapter 7

Positron Emission Tomography Market Size, Opportunities & Strategic Insights, by Technology

7.1Full Ring PET Scanners
7.2Partial Ring PET Scanners
Chapter 8

Positron Emission Tomography Market Size, Opportunities & Strategic Insights, by End Users

8.1Hospitals
8.2Diagnostic Centers
8.3Research Institutes
8.4Others
Chapter 9

Positron Emission Tomography Market, by Region

9.1North America Positron Emission Tomography Market Size, Opportunities, Key Trends & Strategic Insights
9.1.1U.S.
9.1.2Canada
9.2Europe Positron Emission Tomography Market Size, Opportunities, Key Trends & Strategic Insights
9.2.1Germany
9.2.2France
9.2.3UK
9.2.4Italy
9.2.5The Netherlands
9.2.6Rest of EU
9.3Asia Pacific Positron Emission Tomography Market Size, Opportunities, Key Trends & Strategic Insights
9.3.1China
9.3.2Japan
9.3.3South Korea
9.3.4India
9.3.5Australia
9.3.6Thailand
9.3.7Rest of APAC
9.4Middle East & Africa Positron Emission Tomography Market Size, Opportunities, Key Trends & Strategic Insights
9.4.1Saudi Arabia
9.4.2United Arab Emirates
9.4.3South Africa
9.4.4Rest of MEA
9.5Latin America Positron Emission Tomography Market Size, Opportunities, Key Trends & Strategic Insights
9.5.1Brazil
9.5.2Mexico
9.5.3Rest of LA
9.6CIS Positron Emission Tomography Market Size, Opportunities, Key Trends & Strategic Insights
9.6.1Russia
9.6.2Rest of CIS
Chapter 10

Competitive Landscape

10.1Competitive Dashboard & Market Share Analysis
10.2Company Profiles (Overview, Financials, Developments, SWOT)
10.2.1GE Healthcare
10.2.2Siemens Healthineers
10.2.3Philips Healthcare
10.2.4Canon Medical Systems
10.2.5Hitachi Medical
10.2.6Neusoft Medical Systems
10.2.7United Imaging
10.2.8Mediso Medical Imaging Systems
10.2.9CMR Naviscan
10.2.10Spectrum Dynamics Medical
10.2.11Sofie Biosciences